Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Ansar Group, Inc. d/b/a Ansar Medical Technologies, Inc
WARNING LETTER
•Ansar Group, Inc. d/b/a Ansar Medical Technologies, Inc•June 13, 2012

Ansar Group, Inc. d/b/a Ansar Medical Technologies, Inc – FDA Warning Letter, Jun 13, 2012

Record Details

An FDA inspection of Ansar Group, Inc. (Ansar Medical Technologies, Inc.) from May 30 to June 13, 2012, found their ANX Version 3.0 Autonomic Nervous System Monitor adulterated and misbranded. The firm's late response to the FDA 483 was not reviewed. The device is adulterated under 21 U.S.C. § 351(h) due to widespread non-conformity with Quality System (QS) regulation (21 CFR Part 820). Deficiencies include inadequate design controls (plans, input, output, verification, validation, changes, DHF), purchasing controls, finished device acceptance, equipment calibration, complaint handling, management review, quality audits, and personnel training. The device is also misbranded under 21 U.S.C. § 352(t)(2) for failing to comply with Medical Device Reporting (21 CFR Part 803) and Reports of Corrections and Removals (21 CFR Part 806) requirements, specifically lacking written MDR procedures and failing to report a critical device component correction/removal. Furthermore, Ansar Group is promoting and marketing the ANX Version 3.0 for unapproved uses without required marketing clearance or approval. Significant changes to the device's intended use and technology were implemented without new 510(k) notification or PMA, resulting in adulteration under 21 U.S.C. § 351(f)(1)(B) and misbranding under 21 U.S.C. § 352(o). Unsubstantiated labeling claims also risk misbranding under 21 U.S.C. § 352(a). The FDA demands immediate cessation of marketing for unapproved uses and prompt correction of all violations. A comprehensive written response, including corrective actions, prevention plans, documentation, and a timetable, is required within fifteen business days. Non-compliance may lead to severe regulatory actions, including seizure, injunction, civil money penalties, and adverse impacts on business operations and future approvals.

Company
Ansar Group, Inc. d/b/a Ansar Medical Technologies, Inc
Inspection date
June 13, 2012
Product type
Devices
Office
Department of Health and Human Services
People
  • Kirk D. Sooter (District Director)
  • Kristina Donohue (Director )
View Company Profile

ID · 403557d3-c936-407f-b503-ca523cf00369

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 U.S.C. 352(t)(2)21 U.S.C. 351(f)(1)(B)21 U.S.C. 352(o)21 CFR 82021 CFR 820.30(b)21 CFR 820.30(c)21 CFR 820.30(d)21 CFR 820.30(f)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Ansar Group, Inc. d/b/a Ansar Medical Technologies, Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.